|
|
Vaccine Detail
|
Recombinant Adenovirus-Cre Recombinase Vaccine |
| Vaccine Information |
- Vaccine Name: Recombinant Adenovirus-Cre Recombinase Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0007012
- Type: Recombinant vector vaccine
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Host Species as Laboratory Animal Model: Human
- Preparation: The vaccine use an adenovirus vector to deliver Cre-recombinase (Rijnkels and Rosen, 2001).
- Description: This is for Breast Cancer. Please refer to(NCIT_C29785).
|
| Host Response |
|
|
| References |
NCIT_C29785: [https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29785]
Rijnkels and Rosen, 2001: Rijnkels M, Rosen JM. Adenovirus-Cre-mediated recombination in mammary epithelial early progenitor cells. Journal of cell science. 2001; 114(Pt 17); 3147-3153. [PubMed: 11590241].
|
|
